Urgent Pfizer ‘booster’ Dosage Recommendation

US Food and Drug Administration, Monday, by reducing the time between the second and booster dose, and allowing the use of a third dose of Pfizer-Biontech Vaccine For children from 12 to 15 years old.

The CDC also recommended that children who are immunocompromised in any way and between the ages of 5 and 11 years receive an additional dose of the vaccine 28 days following the second dose.

ويد Pfizer Vaccine-Biontech is only available for children ages 5 to 11 in the United States.

It was approved by the US Food and Drug Administration in late October last year.

And it didn’t change US Centers for Disease Control and Prevention Recommendation regarding the interval between the second dose and the booster for persons who received Johnson & Johnson Vaccine Or Moderna, which remains at 2 months for Johnson’s vaccine and 6 months for Moderna.

“>

This move comes on the heels of a decision US Food and Drug Administration, Monday, by reducing the time between the second and booster dose, and allowing the use of a third dose of Pfizer-Biontech Vaccine For children from 12 to 15 years old.

The CDC also recommended that children who are immunocompromised in any way and between the ages of 5 and 11 years receive an additional dose of the vaccine 28 days following the second dose.

ويد Pfizer Vaccine-Biontech is only available for children ages 5 to 11 in the United States.

It was approved by the US Food and Drug Administration in late October last year.

And it didn’t change US Centers for Disease Control and Prevention Recommendation regarding the interval between the second dose and the booster for persons who received Johnson & Johnson Vaccine Or Moderna, which remains at 2 months for Johnson’s vaccine and 6 months for Moderna.

.

Share:

Facebook
Twitter
Pinterest
LinkedIn

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.